Ardent Health Partners, Inc. has a Form S-1 registration statement on file for an initial public offering; the original was filed before the period this page covers, and the earliest filing here is an amendment filed on 2024-07-08. Amendments on record here: 3. It filed its final prospectus on 2024-07-18, at a public offering price of $16.00 per share. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have been approved to list our common stock on the New York Stock Exchange under the symbol ARDT.From the 424B4 filed 2024-07-18
Shares offered
This is the initial public offering of the common stock of Ardent Health Partners, Inc. We are offering 12,000,000 shares of our common stock.From the 424B4 filed 2024-07-18
Offering price
The initial public offering price is $16.00 per share.From the 424B4 filed 2024-07-18
Use of proceeds
However, we currently intend to use the net proceeds of this offering for working capital, to acquire complementary businesses, products, services or technologies and for general corporate purposes, which may include repayment of debt and capital expenditures.From the 424B4 filed 2024-07-18
Revenue
Net patient service revenue per adjusted admission for the three months ended June 30, 2024 is presented as based upon the midpoint of the estimated range of net patient service revenue of a low of $1,399.5 million and a high of $1,461.8 million for the three months ended June 30, 2024.From the S-1/A filed 2024-07-15
Net loss or income
For the year ended December 31, 2023, $1.6 billion of our revenue and $213.7 million of our net income was attributable to our JVs and VIEs, respectively.From the S-1/A filed 2024-07-15
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2024-07-08 | Registration statement amended | S-1/A |
| 2024-07-10 | Registration statement amended | S-1/A |
| 2024-07-15 | Registration statement amended | S-1/A |
| 2024-07-18 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for Ardent Health Partners, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.